E2F6 and ovarian carcinoma: It has been shown that treatment of immortalized ovarian surface epithelial cells with estrogen upregulated E2F6,which, in turn, competitively inhibited the activity of microRNA-193a (which usually prevents cancer stemness), thereby stimulating ovarian cancer stemness and tumorigenesis (Cheng et al., 2019).